Scancell Holdings (SCLP.L) Stock Price
£10.25 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Scancell Holdings, AI stock picks, stock alerts and much more.
SCLP.L AI Stock Analysis
AI stock analysis for SCLP.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Scancell Holdings (SCLP.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Scancell Holdings (SCLP.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Scancell Holdings (SCLP.L), currently trading at £10.25, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SCLP.L
-
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases.
-
Symbol
SCLP.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
106.4M
Similar Stocks
 |
Codexis 0I0X.L |
$3 5.5% |
5 |
 |
Oxford Nanopore Technologies plc ONT.L |
£208.2 1.3% |
7 |
 |
Sareum Holdings SAR.L |
£22 8.3% |
5 |
 |
Viridian Therapeutics 0K1R.L |
$19.19 8.5% |
6 |
 |
Avacta Group Plc AVCT.L |
£49 1% |
4 |
News
SCLP.L Alternative Data
Web Traffic
Scancell Holdings receives an estimated 1455 monthly visitors to scancell.co.uk.
-
Web Traffic
1455
-
Change from Previous Month
239.2%
-
3 Month Change
107.3%
-
YoY Change
107.3%
Twitter Followers
Scancell Holdings has 1,073 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
1073
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.2%
Job Postings
Scancell Holdings currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Scancell Holdings has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Scancell Holdings has 58 employees.
-
LinkedIn Employees
58
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.8%
News Mentions
Scancell Holdings was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
SCLP.L Financials
SCLP.L Key Metrics
-
Total Revenue
£0
-
Net Income
-£3.3M
-
Earnings per Share
-£0.0037
-
Free cash flow
-£9.4M
-
EBITDA
-£4.4M
-
EBITDA Ratio
0
-
Total Assets
£16.6M
SCLP.L 2-year Revenue & Income
SCLP.L 2-year Free Cash Flow
SCLP.L Technicals
SCLP.L SMA
SCLP.L RSI
FAQ
What's the current price of Scancell Holdings (SCLP.L) Stock?
The price of an Scancell Holdings (SCLP.L) share is £10.25.
What's the market cap of Scancell Holdings?
The current market cap of Scancell Holdings is 106.4M.
Should I buy or sell SCLP.L?
Scancell Holdings shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Scancell Holdings is better viewed as a hold or accumulate position while waiting for further developments.
Is Scancell Holdings a good investment?
The current analysis of Scancell Holdings' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Scancell Holdings' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Scancell Holdings (SCLP.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Scancell Holdings stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Scancell Holdings (SCLP.L) that investors often compare it to?
Scancell Holdings (SCLP.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Scancell Holdings' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Scancell Holdings' stock price to be around £9.67 in 2026. Starting from the current price of £10.25, this represents a 5.7% change in price, indicating a bearish outlook for the stock.
How to buy Scancell Holdings (SCLP.L) Stock?
Scancell Holdings stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Scancell Holdings shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.